
Ferric Derisomaltose Generics
Form: IV Infusion
Strength: 200 mg/ml
Reference Brands: Monoferric® (U.S.) and Monofer® (EU))
Category: Anemia
Ferric Derisomaltose, marketed as Monoferric® in the U.S. and Monofer® in the EU, is a next-generation intravenous iron therapy used for treating iron deficiency anemia in adults, particularly when oral iron is ineffective or not tolerated. Its high-concentration formulation (200 mg/mL) allows for single high-dose administration, improving patient compliance and reducing treatment time. In the pharmaceutical B2B market, Ferric Derisomaltose is in high demand across hospitals, dialysis centers, and specialty clinics. In both the U.S. and EU, it is supplied under GMP conditions for institutional supply, private labeling, and international distribution through licensed manufacturers and contract partners
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Deferoxamine
Strength: 500 mg/vial, 2 g/vial
Form: Lyophilized powder for injection
Reference Brands: Desferal
View Details Get EnquiryDeferasirox
Strength: 125 mg, 250 mg, 500 mg
Form: Tablets for Oral Suspension
Reference Brands: Exjade, Jadenu (film-coated)
View Details Get EnquiryIron(III)-Isomaltoside Injection
Strength: 100mg/ml
Form: Injection
Reference Brands: Monofer,, Diafer, Monoferric
View Details Get EnquiryIron Dextran
Strength: 50 mg/mL
Form: injection
Reference Brands: Dexferrum,INFeD
View Details Get Enquiry